Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients

BACKGROUND Aberrant activation of phosphorylated form of glycogen synthase kinase-3β [pS9GSK-3β (Serine 9 phosphorylation)] is known to trigger Wnt/β-catenin signal cascade but its clinicohistopathological implications in bladder carcinogenesis remain unknown. AIM To investigate the diagnostic and prognostic relevance of expressions of pS9GSK-3β, β-catenin and its target genes in the pathobiology of bladder cancer. METHODS Bladder tumor tissues from ninety patients were analyzed for quantitative expression and cellular localization of pS9GSK-3β by immunohistochemical (IHC) staining. Real time-quantitative polymerase chain reaction and IHC were done to check the expression of β-catenin, Cyclin D1, Snail and Slug at transcriptome and protein level respectively. Clinicohistopathological variables were obtained from histology reports, follow up and OPD visits of patients. Expressions of the markers were statistically correlated with these variables to determine their significance in clinical setting. Results were analysed using SPSS 20.0 software. RESULTS Aberrant (low or no membranous/high nuclear/high cytoplasmic) expression of pS9GSK-3β was noted in 51% patients and found to be significantly associated with tumor stage and tumor grade (P = 0.01 and 0.04; Mann Whitney U test). Thirty one percent tumors exhibited aberrant co-expression of pS9GSK-3β and β–catenin proteins and showed strong statistical association with tumor stage, tumor type, smoking/tobacco chewing status (P = 0.01, 0.02 and 0.04, Mann-Whitney U test) and shorter overall survival probabilities of patients (P = 0.02; Kaplan Meier test). Nuclear immunostaining of Cyclin D1 in tumors with altered pS9GSK-3β/β–catenin showed relevance with tumor stage, grade and type. CONCLUSION β–catenin and pS9GSK-3β proteins are identified as markers of diagnostic/prognostic significance in disease pathogenesis. Observed histopathological association of Cyclin D1 identifies it as marker of potential relevance in tumors with altered pS9GSK-3β/β-catenin.

[1]  M. Garg.  Epithelial plasticity and metastatic cascade , 2018, Expert opinion on therapeutic targets.

[2]  Lijie Zhou,et al.  HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β‐catenin signaling , 2018, Molecular carcinogenesis.

[3]  Tiancheng Xie,et al.  Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells. , 2017, Oncology reports.

[4]  L. Gan,et al.  Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis. , 2017, Oncology reports.

[5]  Y. Chun,et al.  Human steroid sulfatase induces Wnt/β-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1α in human prostate and cervical cancer cells , 2017, Oncotarget.

[6]  Zhe Zhu,et al.  Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β‐catenin signalling pathway , 2017, Journal of cellular and molecular medicine.

[7]  F. Halaweish,et al.  Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression , 2017, Molecular Cancer Therapeutics.

[8]  J. Ansari,et al.  Epithelial‐To‐Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder , 2017, Clinical genitourinary cancer.

[9]  Xuan Liang,et al.  Silencing of Armadillo Repeat-Containing Protein 8 (ARMc8) Inhibits TGF-β-Induced EMT in Bladder Carcinoma UMUC3 Cells , 2017, Oncology research.

[10]  Wenxin Qin,et al.  Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3β/β-catenin Signaling , 2016, Theranostics.

[11]  M. Garg.  Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer , 2015, Cancer and Metastasis Reviews.

[12]  H. Miyake,et al.  Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection. , 2015, Urologic oncology.

[13]  E. El-Sherif,et al.  Evaluation of β-catenin expression in muscle-invasive urothelial bladder carcinoma , 2014 .

[14]  Xin-yang Wang,et al.  Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. , 2013, Urologic oncology.

[15]  B. Jiang,et al.  Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer. , 2013, European journal of cancer.

[16]  G. Xiao,et al.  Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer , 2013, Journal of Translational Medicine.

[17]  Weiling Zhao,et al.  ERK/GSK3β/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. , 2012, Free radical biology & medicine.

[18]  A. Chien,et al.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. , 2012, Gastroenterology.

[19]  R. Holcombe,et al.  Wnt signaling and colon carcinogenesis: Beyond APC , 2011, Journal of carcinogenesis.

[20]  V. Bilim,et al.  Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer , 2010, Clinical Cancer Research.

[21]  Jia Luo,et al.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. , 2009, Cancer letters.

[22]  B. Olsen,et al.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.

[23]  G. Berx,et al.  Snail promotes Wnt target gene expression and interacts with β-catenin , 2008, Oncogene.

[24]  R. Dahiya,et al.  Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway , 2006, Clinical Cancer Research.

[25]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[26]  A. G. de Herreros,et al.  Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription , 2005, The Journal of cell biology.

[27]  G. Apodaca.  The Uroepithelium: Not Just a Passive Barrier , 2004, Traffic.

[28]  T. Dale,et al.  Protein Kinase B/Akt Acts via Glycogen Synthase Kinase 3 To Regulate Recycling of αvβ3 and α5β1 Integrins , 2004, Molecular and Cellular Biology.

[29]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[30]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.

[31]  M. Hung,et al.  β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .

[32]  V. Bilim,et al.  Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[34]  Philip R. Cohen,et al.  Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). , 1984, Biochimica et biophysica acta.

[35]  Lijie Zhou,et al.  HBO 1 promotes cell proliferation in bladder cancer via activation of Wnt / β-catenin signaling † Running title : HBO 1 promotes bladder cancer proliferation , 2017 .

[36]  J. Ro,et al.  Differential expression of GSK3β and pS9GSK3β in normal human tissues: can pS9GSK3β be an epithelial marker? , 2015, International journal of clinical and experimental pathology.

[37]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[38]  A. Harwood,et al.  The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle. , 2003, Progress in cell cycle research.

[39]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. , 2000, Nature.

[40]  M. Hung,et al.  Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Polakis,et al.  Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. , 1996, Science.

[42]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.